Page last updated: 2024-09-03

kca 098 and coumestrol

kca 098 has been researched along with coumestrol in 10 studies

Compound Research Comparison

Studies
(kca 098)
Trials
(kca 098)
Recent Studies (post-2010)
(kca 098)
Studies
(coumestrol)
Trials
(coumestrol)
Recent Studies (post-2010) (coumestrol)
10003052111

Protein Interaction Comparison

ProteinTaxonomykca 098 (IC50)coumestrol (IC50)
SUMO-1Homo sapiens (human)14.7
rac GTPase-activating protein 1 isoform aHomo sapiens (human)32.34
Estrogen receptorHomo sapiens (human)0.0433
Casein kinase II subunit alpha'Homo sapiens (human)0.2
Casein kinase II subunit betaHomo sapiens (human)0.2
Casein kinase II subunit alphaHomo sapiens (human)0.2
Casein kinase II subunit alpha 3Homo sapiens (human)0.2
Estrogen receptor betaHomo sapiens (human)0.0131

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's8 (80.00)18.2507
2000's2 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arai, N; Endo, H; Itoh, F; Kawashima, K; Kojima, M; Nagata, H; Tsutsumi, N; Tsuyuki, J; Ujiie, A1
Endo, H; Itoh, F; Kawashima, K; Kojima, M; Nagata, H; Okazaki, M; Tsutsumi, N; Ujiie, A2
Arai, N; Endo, H; Kawashima, K; Kojima, M; Nagata, H; Tsutsumi, N; Ujiie, A1
Iizuka, K; Ikegami, K; Otagiri, M; Saito, N; Toda, M; Yamada, T1
Endo, H; Inoue, T; Kawashima, K; Tsutsumi, N1
Imai, T; Otagiri, M; Saito, N; Yamada, T1
Fujioka, M; Imai, I; Miyagi, M; Otagiri, M; Saito, N; Yamada, T; Yamamoto, A1
Hirayama, F; Imai, T; Otagiri, M; Ouchi, K; Uekama, K; Yamada, T1
Anraku, M; Imai, T; Otagiri, M; Saito, N; Yamada, T1

Other Studies

10 other study(ies) available for kca 098 and coumestrol

ArticleYear
Effects of KCA-098 on bone metabolism: comparison with those of ipriflavone.
    Japanese journal of pharmacology, 1994, Volume: 65, Issue:4

    Topics: 24,25-Dihydroxyvitamin D 3; Animals; Bone and Bones; Bone Density; Bone Resorption; Calcification, Physiologic; Calcium; Calcium, Dietary; Chick Embryo; Coumestrol; Dinoprostone; Female; Femur; Interleukin-1; Isoflavones; Osteoporosis; Ovariectomy; Parathyroid Hormone; Rats; Rats, Wistar

1994
Induction of osteopenia in confined rats.
    Biological & pharmaceutical bulletin, 1994, Volume: 17, Issue:7

    Topics: Animals; Bone Diseases, Metabolic; Bone Resorption; Coumestrol; Disease Models, Animal; Immobilization; Male; Rats; Rats, Wistar

1994
In vitro effect of KCA-098, a derivative of coumestrol, on bone resorption of fetal rat femurs.
    Bone and mineral, 1994, Volume: 24, Issue:3

    Topics: Animals; Bone Resorption; Calcification, Physiologic; Calcium; Coumestrol; Estradiol; Female; Femur; Organ Culture Techniques; Organ Size; Ovariectomy; Parathyroid Hormone; Phosphorus; Pregnancy; Rats; Rats, Wistar; Uterus

1994
Effect of KCA-098, a new benzofuroquinoline derivative, on bone mineral metabolism.
    Biological & pharmaceutical bulletin, 1994, Volume: 17, Issue:4

    Topics: Animals; Bone and Bones; Bone Density; Bone Development; Bone Resorption; Calcium; Chick Embryo; Coumestrol; Culture Techniques; Dose-Response Relationship, Drug; Female; Femur; Ovariectomy; Phosphorus; Rats; Rats, Wistar

1994
[Polymorphism of 3,9-bis-(N,N-dimethylcarbamoyloxy)-5H-benzofuro[3,2- c]quinoline-6-one(KCA-098), a new benzofuroquinoline derivative].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 1995, Volume: 115, Issue:12

    Topics: Chemical Phenomena; Chemistry, Physical; Coumestrol; Crystallization; Solubility; X-Ray Diffraction

1995
Effect of KCA-098 on the function of osteoblast-like cells and the formation of TRAP-positive multinucleated cells in a mouse bone marrow cell population.
    Biochemical pharmacology, 1996, Jan-26, Volume: 51, Issue:2

    Topics: Acid Phosphatase; Alkaline Phosphatase; Animals; Bone Marrow; Bone Resorption; Cell Division; Collagen; Coumestrol; Estradiol; Isoenzymes; Male; Mice; Osteoblasts; Osteocalcin; Structure-Activity Relationship; Tartrate-Resistant Acid Phosphatase

1996
Effect of grinding with hydroxypropyl cellulose on the dissolution and particle size of a poorly water-soluble drug.
    Chemical & pharmaceutical bulletin, 1999, Volume: 47, Issue:9

    Topics: Cellulose; Coumestrol; Drug Compounding; Particle Size; Povidone; Solubility; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction

1999
Characterization of urinary metabolites of a new benzofuroquinoline derivative, 3,9-bis(N,N-dimethylcarbamoyloxy)-5 H-benzofuro[3,2-c]-quinoline-6-one (KCA-098), in dogs.
    Die Pharmazie, 1999, Volume: 54, Issue:9

    Topics: Animals; Biotransformation; Chromatography, High Pressure Liquid; Coumestrol; Dealkylation; Dogs; Hydrolysis; Hydroxylation; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry

1999
Inclusion complex of 3,9-bis(N,N-dimethylcarbamoyloxy)-5H-benzofuro[3,2-c]quinoline-6-one (KCA-098) with heptakis(2,6-di-O-methyl)-beta-cyclodextrin: interaction and dissolution properties.
    Chemical & pharmaceutical bulletin, 2000, Volume: 48, Issue:9

    Topics: beta-Cyclodextrins; Calorimetry, Differential Scanning; Chemical Phenomena; Chemistry, Physical; Chromatography, Gas; Coumestrol; Cyclodextrins; Solubility; Solvents; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; X-Ray Diffraction

2000
Physicochemical characterization of a new crystal form and improvements in the pharmaceutical properties of the poorly water-soluble antiosteoporosis drug 3,9-bis(N,N-dimethylcarbamoy-loxy)-5H-benzofuro[3,2-c]quinoline-6-one (KCA-098) by solid dispersion
    Pharmaceutical development and technology, 2000, Volume: 5, Issue:4

    Topics: Absorption; Animals; Cellulose; Coumestrol; Crystallization; Dogs; Male; Osteoporosis; Powders; Solubility; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction

2000